Lannett Company, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 95   

Articles published

LCI 67.40 0.00 (0.00%)
price chart
Reasons for Arthur Bedrosian's Shares Unload of Lannett Company, Inc. (NYSE ...
Arthur Bedrosian; that is an insider in Lannett Company, Inc. (NYSE:LCI) 66.45 -0.28 -0.42% who is the latest to sell shares in the firm for which he is currently the CEO.
Insider Selling: Arthur P. Bedrosian Sells 5000 Shares of Lannett Company ...  WKRB News
Lannett Has A Bright Future Ahead (LCI)
Lannett's (NYSE:LCI) share value has gone up by 41% in a year. The company is a manufacturer of generic thyroid, cardiovascular and pain-management drugs.
Research Analysts' Weekly Ratings Changes for Lannett Company (LCI)  Dakota Financial News
Lannett Company, Inc. (NYSE:LCI) Looking for a Significant EPS growth for the ...
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products in the United States.
Lannett Company major shareholder David Farber Sells 2500 Shares (LCI)  Ticker Report
Bull of the Day: Lannett (LCI)
Deadline in Lawsuit for Investors in Lannett Company, Inc. Shares Announced ...
SAN DIEGO, Sept. 9, 2014 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of shares of Lannett Company, Inc. (NYSE:LCI) over alleged Violations of Federal Securities Laws by ...
Related articles »  
Lannett Corporation: Strong Growth And Margin Expansion Will Continue (LCI)
Given the fact that Lannett is a generic drug manufacturer, this is without a doubt, great news. As these branded drugs lose their patent protection, Lannett can begin manufacturing them freely and expanding the array of drugs that the company sells.
Insider Selling: Lannett Company CEO Sells $347150.00 in Stock (LCI)
Lannett Company, Inc develops, manufactures, packages, markets and distributes solid oral (NYSE:LCI), extended release, topical and oral solution finished dosage forms of drugs.
Philadelphia drug company subpoenaed, stock price falls
Lannett Co. Inc.'s stock price dropped more than 8 percent in mid-day trading Thursday after the Northeast Philadelphia generic pharmaceutical company announced that it was hit with a grand jury subpoena this week.
Lannett Company: Pre-Announcement May Suppress Stock's Reaction To Q2 ...
If you've been watching Lannett Company (NYSE:LCI) over the last calendar year, you would know that the stock is not for the faint of heart, as shares have been very volatile to say the least.
Update: Lannett Fiscal Q1 2015 Earnings (LCI)
Lannett (NYSE:LCI) reported fiscal Q1 2015 earnings and revenue that easily surpassed analyst estimates. The earnings and revenue beat comes despite the fact that the company preannounced the results two weeks ago. Lannett continues to raise prices ...
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Lannett ...
4, 2014 /PRNewswire-USNewswire/ -- Ryan & Maniskas, LLP announces that a class action lawsuit has been filed in United States District Court for the Eastern District of Pennsylvania on behalf of investors who acquired Lannett Company, Inc. ("Lannett ...
Related articles »